- ►diabetesjournals.org M Massi-Benedetti, M Orsini-Federici - Diabetes Care, 2008 - Am Diabetes Assoc Type 2 diabetes is a progressive syndrome that evolves toward complete insulin deficiency during the
patient's life. A stepwise approach for its treatment should be tailored according to the natural
course of the disease, including ... Cited by 3 - Related articles - BL Direct - All 5 versions
J Rosenstock, HS Chou, S Matthaei, DK … - Diabetes Obes …, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets. In
this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the ... Cited by 2 - Related articles - All 2 versions
KL Edwards, C Alvarez, BK Irons, J Fields - Pharmacotherapy, 2008 - PPI Patients with type 2 diabetes mellitus often begin treatment by taking oral agents, usually
metformin or a sulfonylurea, and then progress to the combination of these two agents. Most patients
often require three or more agents ... Cited by 3 - Related articles - BL Direct - All 3 versions
[CITATION] for the Troglitazone and Exogenous Insulin Study Group: Effect of troglitazone in …
F Abbasi, HMF Farin, C Lamendola, L McGraw, T … - Metabolism, 2008 - Elsevier Insulin sensitivity varies in cigarette smokers, and there is evidence that cardiovascular disease
(CVD) risk is greatest in those smokers who are also insulin resistant. To extend these
observations, we sought to (1) ... Cited by 4 - Related articles - All 19 versions
S Piquer, S Barceló-Batllori, M Julià, N Marzo, B … - … and Biophysical Research …, 2007 - Elsevier Oral administration of sodium tungstate is an effective treatment for diabetes in animal models.
Several lines of evidence indicate the pancreatic beta cell as one of the targets of tungstate
action. Here, we examined the ... Cited by 4 - Related articles - All 5 versions
S Singh, YK Loke - Expert Opin. Drug Saf., 2008 - informahealthcare.com Background: Cardiovascular disease is the leading cause of mortality among adults with Type 2
diabetes. The thiazolidinediones including rosiglitazone are approved for the treatment of Type 2
diabetes on the basis of their ... Cited by 6 - Related articles - All 4 versions
C Giaginis, A Tsantili-Kakoulidou, S … - Fundamental and …, 2007 - interscience.wiley.com Peroxisome proliferator-activated receptors (PPARs) are ligand-activated nuclear transcription
factors that regulate the storage and catabolism of dietary fats. PPARs constitute molecular targets
for the treatment of human ... Cited by 6 - Related articles - BL Direct - All 4 versions
[CITATION] on behalf of the PROactive investigators. Safety and tolerability of pioglitazone in …
- ►mcponline.org S Barcelo-Batllori, SG Kalko, Y Esteban, S Moreno, … - Molecular & Cellular …, 2008 - ASBMB Our previous results demonstrated that tungstate decreased weight gain and adiposity in obese rats
through increased thermogenesis and lipid oxidation, suggesting that brown adipose tissue was one of
the targets of its antiobesity ... Cited by 6 - Related articles - BL Direct - All 4 versions
